Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The aim of this study is to describe and compare the onset of neuromuscular block and recovery after reversal of NMBAs at two different muscle/nerve units: foot (posterior tibial n. and flexor hallucis brevis m.) and forearm (ulnar n. and adductor pollicis m.), as measured by a new quantitative monitor, the electromyography-based TetraGraph

Trial Profile

The aim of this study is to describe and compare the onset of neuromuscular block and recovery after reversal of NMBAs at two different muscle/nerve units: foot (posterior tibial n. and flexor hallucis brevis m.) and forearm (ulnar n. and adductor pollicis m.), as measured by a new quantitative monitor, the electromyography-based TetraGraph

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Dec 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sugammadex (Primary)
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use

Most Recent Events

  • 03 Dec 2021 New trial record
  • 12 Oct 2021 Results presented at the ANESTHESIOLOGY 2021 Annual Meeting of the American Society of Anesthesiologists

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top